UPClytics

Tandem Diabetes Care Group

Operating company

HQ: United States

Total cases
18
Claimant-side
9
Respondent-side
9

Tandem Diabetes Care Group has been party to 18 Unified Patent Court cases, 9 times as claimant and 9 times as respondent. The most recent on record is UPC CoA 120/2025 at the Court of Appeal. Its most recent decision on the merits was in UPC CFI 454/2023 at the Paris Central Division on 18 December 2024: patent upheld as granted.

Group members
2 entities · 18 cases combined
Top opponents
  • Roche Group18

More opponents

Top opponent firms
  • Kather Augenstein16

More opposing firms

Top firms retained
  • Taylor Wessing16

More of its firms

Start 14-day free trialEvery opponent and every firm acting for and against Tandem Diabetes Care Group.Already a user? Sign in
Recent cases
Latest filings involving this group and its entities.
View all cases
  • 2025-02-17UPC CoA 120/2025SettledTandem Diabetes Care Europe B.V. v Roche Diabetes Care GmbH
  • 2025-01-20UPC CFI 11/2025Costs onlyRoche Diabetes Care GmbH v Tandem Diabetes Care, Inc.
  • 2024-04-19CC 20972/2024—Rubin Medical ApS v F. Hoffmann-La Roche AG
  • 2024-02-29UPC CFI 88/2024SettledRoche Diabetes Care GmbH v Tandem Diabetes Care, Inc.
  • 2024-01-02UPC CFI 504/2023SettledF. Hoffmann-La Roche AG v Tandem Diabetes Care, Inc.
  • 2023-11-30UPC CFI 454/2023Patent upheld as grantedTandem Diabetes Care, Inc. v Roche Diabetes Care GmbH
  • 2023-11-30UPC CFI 455/2023SettledTandem Diabetes Care, Inc. v Roche Diabetes Care GmbH
  • —UPC APP 11294/2025Procedural onlyF. Hoffmann-La Roche AG v Tandem Diabetes Care, Inc.
  • —UPC APP 23079/2025Procedural onlyF. Hoffmann-La Roche AG v Tandem Diabetes Care, Inc.
  • —UPC APP 28226/2025Procedural onlyF. Hoffmann-La Roche AG v Tandem Diabetes Care, Inc.